Contract Research Organisation (CRO) developing ex vivo human skin platforms capable of testing injected drugs and implanted medical devices
Genoskin has raised €7.3M across 1 funding round from 8 investors, most recently a round in Sep 2025. Based in Toulouse, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-17 | Other | €7.3M |
| BNP Paribas,Bpifrance,CA Toulouse 31 Initiatives,Caisse d’Epargne Midi-Pyrénées,Captech Santé,Crédit Agricole+2 more |
| View deal → |
